EAGLE PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.61 USD | +2.90% |
|
+0.44% | -11.85% |
| Apr. 15 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
| Apr. 15 | Sector Update: Health Care | MT |
Chart calendar Eagle Pharmaceuticals, Inc.
ef4a78d260196b5bd6042fb.tsHCdUJbVWp9C9NbBgciZkTDmqVq4Gi-cAftRexAicM.xpirRhodEB4oTbIWcldBKACGwJc60ATpIjW6d7Qa7pP-goEzFAkjKS5phg~03515dbe35121bf3375669146323504c
Upcoming events on Eagle Pharmaceuticals, Inc.
Past events on Eagle Pharmaceuticals, Inc.
| 2024-04-16 12:00 pm | American Society of PeriAnesthesia Nurses National Conference |
| 2024-04-16 07:00 am | American Society of PeriAnesthesia Nurses National Conference |
| 2024-02-27 | Q4 2023 Earnings Release (Projected) |
| 2023-12-10 03:30 pm | New York State Society of Anesthesiologists Conference |
| 2023-11-09 08:30 am | Q3 2023 Earnings Call |
| 2023-11-09 06:50 am | Q3 2023 Earnings Release |
| 2023-10-13 03:00 pm | American Society of Anesthesiologists Meeting |
| 2023-09-27 02:25 pm | Cantor Global Healthcare Conference |
| 2023-09-20 03:35 pm | ASM & ESCMID Meeting |
| 2023-09-12 02:00 pm | H.C. Wainwright Global Investment Conference |
| 2023-09-09 03:45 pm | Society for Neuroscience in Anesthesiology and Critical Care Meeting |
| 2023-09-07 08:00 am | Citi BioPharma Conference |
| 2023-08-08 08:30 am | Q2 2023 Earnings Call |
| 2023-08-08 06:50 am | Q2 2023 Earnings Release |
| 2023-06-28 10:00 am | Annual General Meeting |
| 2023-05-18 03:38 pm | Society for Academic Emergency Medicine Meeting - Abstract No:359 |
| 2023-05-17 05:16 pm | Society for Academic Emergency Medicine Meeting - Abstract No:207 |
| 2023-05-09 08:30 am | Q1 2023 Earnings Call |
| 2023-05-09 06:50 am | Q1 2023 Earnings Release |
| 2023-03-15 02:35 pm | Barclays Global Healthcare Conference - Fireside Chat |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 213 211 0.89% | 196 197 -0.49% | 188 190 -1.02% | 172 181 -5.1% | 317 320 -1.11% |
|
EBITDA Million USD | Released Forecast Spread | 71,4 74,4 -4.07% | 49,0 49,3 -0.51% | 64,7 44,5 45.32% | 43,5 45,9 -5.13% | 132 127 4.11% |
|
EBIT Million USD | Released Forecast Spread | 70,2 70,9 -0.94% | 48,1 48,3 -0.46% | 64,7 47,5 36.15% | 2,77 5,45 -49.23% | 132 129 1.75% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 34,0 34,5 -1.22% | 22,0 0,00 - | 22,7 -7,11 418.81% | -4,55 0,83 -645.32% | 61,4 42,3 45.24% |
|
Net income Million USD | Released Forecast Spread | 31,9 31,2 2.22% | 14,3 12,4 15.43% | 12,0 -14,5 182.85% | -8,63 2,88 -399.97% | 35,6 20,4 74.54% |
|
EPS USD | Released Forecast Spread | 2,09 2,03 2.96% | 1,01 0,87 16.09% | 0,87 -1,07 181.31% | -0,66 0,22 -400% | 2,73 1,56 75% |
| Announcement Date | 28/02/19 | 02/03/20 | 02/03/21 | 07/03/22 | 13/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 48,1 45,9 4.93% | 39,9 45,9 -13.22% | 42,3 51,1 -17.15% | 116 123 -6.12% | 74,1 117 -36.57% | 65,9 62,1 6.16% | 60,7 64,3 -5.54% | 66,3 63,3 4.77% | 64,6 59,4 8.9% |
|
EBITDA Million USD | Released Forecast Spread | 11,7 12,9 -8.7% | 9,81 13,7 -28.24% | 13,5 14,9 -9.79% | 25,9 49,5 -47.58% | 19,3 15,0 28.56% | 20,0 10,0 98.9% | 22,3 20,9 6.61% | 20,7 19,9 3.69% | |
|
EBIT Million USD | Released Forecast Spread | 10,8 14,6 -25.87% | 8,91 14,4 -38.15% | 5,90 8,84 -33.26% | 61,7 66,3 -6.91% | 24,3 59,4 -59.07% | 18,9 15,9 19.09% | 19,8 17,6 13% | 16,8 17,0 -1.34% | 14,7 17,0 -13.55% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 5,55 3,41 62.94% | -12,7 -7,47 -69.46% | 1,22 6,86 -82.16% | -5,87 40,8 -114.37% | -0,05 3,96 -101.14% | 13,3 -5,83 328.16% | 10,2 6,69 53.02% | 9,30 7,68 21.02% | |
|
Net income Million USD | Released Forecast Spread | 3,61 2,69 34.28% | -5,62 -5,90 4.74% | -6,20 5,42 -214.32% | 44,1 42,0 4.9% | -9,45 32,3 -129.3% | -3,51 3,13 -212.24% | 8,17 -7,06 215.72% | 5,75 5,28 8.86% | 5,16 5,76 -10.38% |
|
EPS USD | Released Forecast Spread | 0,27 0,21 28.57% | -0,43 -0,44 2.27% | -0,48 0,41 -217.07% | 3,41 3,88 -12.11% | -0,74 2,48 -129.84% | -0,27 0,23 -217.39% | 0,62 -0,54 214.81% | 0,44 0,40 10% | 0,39 0,44 -11.36% |
| Announcement Date | 09/08/21 | 09/11/21 | 07/03/22 | 09/05/22 | 09/08/22 | 07/11/22 | 13/03/23 | 09/05/23 | 08/08/23 |
More events
Past sector events for Eagle Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EGRX Stock
- Calendar Eagle Pharmaceuticals, Inc.
